Wall Street brokerage firms have already issued a rating of hold on the stocks of HRZN, with close to eight analysts working on the firm. According to reports, two of the research investment analysts have already given the stocks a rating of sell, while three of them have given it a rating of hold. Two other analysts gave the company a rating of buy. Currently, HRZN enjoys a price target of $10.50, which has been calculated over the average year.
The Quarterly Earnings of HRZN
There have been quite a few research equities that have commented on the stocks of HRZN. Compass Point has already redacted the rating of the company from neutral to sell, along with a price target of $9.50 on the stocks of the firm. B. Riley has also reiterated the previous rating of neutral in a 24th November research note. In the end, Zacks Investment also gave the company a rating of sell, after it previously had a rating of hold in a 5th January research report.
The stocks of HRZN traded on Tuesday at $13.66. The moving average price of the company over 50 days was $13.27, while the moving average price of the firm over 200-days is $12.3. The market cap of HRZN is $250.91 million, with a 1.10 beta, and a 19.80 PE ratio.
HRZN had previously brought out its quarterly earnings on the 8th of November. According to reports, the company dealing in investment management had reported an EPS of $0.38 in the quarter, which was more than the consensus estimate put forward by Thomson Reuters. HRZN also had an 11.89% return on its equity with a 21.85$ net margin. The revenue of the firm for the quarter was $12.33 million, which was comprehensively more than the consensus estimate of $11.86 million.
